GoodRx reports Q1 adjusted EPS 7c, consensus 7c

Reports Q1 revenue $194M, consensus $185.12M. “We delivered a strong start to the year, with continued momentum across our strategic growth priorities,” said Wendy Barnes, President and Chief Executive Officer of GoodRx (GDRX). “Our results demonstrate that the strategy we laid out last quarter is working and that we are building a sustainable value proposition. We believe that momentum is driving durable growth and increasing value for consumers and our partners.”